Rotation Medical touted data today from the 1st study of its collagen-based bioinductive implant in patients with large and massive rotator cuff tears. The results were presented at the American Academy of Orthopedic Surgeons in San Diego. The data demonstrated that the company’s implant induced new tissue formation in all 23 participants. “Failure of large […]
Clinical Trials
J&J’s DePuy Synthes touts economic benefits shown in Attune knee study
Johnson & Johnson (NYSE:JNJ) subsidiary DePuy Synthes this week released data from a new report on its Attune knee system, touting the economic benefits and value of procedures with the system to the new value-based healthcare environment. In the report, researchers analyzed approaches for evaluating primary total knee arthroplasty procedures and assessed data from DePuy’s […]
InVivo wins initial clearance to add UK trial sites to Inspire study
InVivo Therapeutics (NSDQ:NVIV) said today it won approval to commence clinical trials in the UK from the Medicines Healthcare Products Regulatory Agency. The Cambridge, Mass.-based company said it is in late-stage conversation with various clinical sites in the UK to join the Inspire study of its neuro-spinal scaffold, with a hopeful 1st opening “in the coming […]
Prometra micro-infusion device used to deliver meds directly to brain in epilepsy trial
Flowonix Medical and Cerebral Therapeutics said today that the 1st patients were implanted with the Prometra II programmable infusion system in a clinical trial evaluating the pump in patients with refractory epilepsy. The Address trial marks the 1st time a programmable, implantable pump has been used to deliver medication, in this case valproate, directly to […]
Ocular touts patient experience data for Dextenza implant
Ocular Therapeutix (NSDQ:OCUL) touted data today from a patient experience study of its Dextenza post-surgical pain relief implant. The study was published in Patient Preference and Adherence. The Bedford, Mass.-based company’s hydrogel plug, inserted into a patient’s tear duct, is designed to deliver a sustained dose of dexamethasone over 4 weeks following ophthalmic surgery. After the […]
Abiomed touts reduced acute kidney risk in Impella-supported PCI study
Abiomed (NSDQ:ABMD) today released data from a study which utilized its Impella 2.5 heart pump for hemodynamic support during high-risk percutaneous coronary interventions, touting reduced risk of acute kidney injury in patients with preexisting kidney disease and low ejection fraction. Data from the study were recently published in the journal Circulation Research, the Danvers, Mass.-based […]
Pacira touts Phase IV study of Exparel anesthetic in total knee arthroplasty
Pacira Pharmaceuticals (NSDQ:PCRX) said today the Phase IV study of its Exparel bupivacaine liposome injection in patients undergoing total knee arthroplasty met its co-primary endpoints for postsurgical pain and opioid reduction. The anesthetic achieved statistical significance for secondary endpoints including time to 1st opioid use and the percentage of patients who did not require opioids […]
Masimo touts study of SpHb monitoring tech
Masimo (NSDQ:MASI) today released results from a study which compared the company’s noninvasive SpHb measurement to conventional laboratory HbL measurements for patients undergoing liver transplantation, touting equivalence between the 2 methods. Researchers in the study reported that Masimo’s SpHb monitoring had “clinically acceptable accuracy of hemoglobin measurement [compared] with a standard laboratory device when used during […]
Cartiva touts 5-year synthetic cartilage study data
Cartiva touted 5-year data for its synthetic cartilage implant in patients with arthritis at the base of the big toe. The data, which included results from 27 patients, were published in Foot and Ankle International. The study found that patients experienced a 91% mean reduction in pain after 5 years and a 128% mean improvement in sporting […]
Aethlon touts Hemopurifier feasibility study results
Aethlon Medical (NSDQ:AEMD) said today that it finished an FDA-approved feasibility study for its Hemopurifier device in health-compromised patients. Previously, the device was used under the FDA’s emergency-use authorization in patients infected with Hepatitis C, HIV and the Ebola virus. Aethlon’s Hemopurifier device is a single-use, disposable cartridge designed to target and filter out viruses or tumor-secreted […]
BioTime expands OpRegen dry-AMD trial with U.S. sites
BioTime Inc. (NYSE:BTX) said today that it expanded its OpRegen Phase I/IIa trial into the U.S. with 2 new trial sites. The company’s study is evaluating its OpRegen cell therapy in patients with advanced dry form age-related macular degeneration. The 2 U.S.-based trial sites will include ophthalmologists Dr. David Boyer from the Retina-Vitreous Associates Medical Group […]